Search for author "A. Michael Lincoff"
297 Results
- Table 5.Open AccessAssociations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long‐Term Mortality After Noncardiac Vascular SurgeryGrant W. Reed, Samuel Horr, Laura Young, Joshua Clevenger, Umair Malik, Stephen G. Ellis, A. Michael Lincoff, Steven E. Nissen, Venu MenonJournal of the American Heart Association June 2017, 6 (6) e005672; DOI: https://doi.org/10.1161/JAHA.117.005672By Grant W. Reed, Samuel Horr, Laura Young, Joshua Clevenger, Umair Malik, Stephen G. Ellis, A. Michael Lincoff, Steven E. Nissen and Venu Menon
- Open AccessSafety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical PerspectiveThe AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. HarringtonCirculation. 2016;134:1918-1930, originally published November 15, 2016https://doi.org/10.1161/CIRCULATIONAHA.116.025687
- Table 1.Open AccessSafety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical PerspectiveC. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. HarringtonCirculation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
- Figure 1.Open AccessSafety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical PerspectiveC. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. HarringtonCirculation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
- Table 2.Open AccessSafety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical PerspectiveC. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. HarringtonCirculation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
- Table 3.Open AccessSafety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical PerspectiveC. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. HarringtonCirculation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
- Figure 2.Open AccessSafety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical PerspectiveC. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. HarringtonCirculation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. HarringtonTime to occurrence of first major adverse cardiovascular event (MACE). Composite of cardiov...Show MoreTime to occurrence of first major adverse cardiovascular event (MACE). Composite of cardiovascular (CV) death, nonfatal myocardial infarction (MI), ischemic stroke, and hospitalization for unstable angina. HR indicates hazard ratio.Show Less
- Figure 3.Open AccessSafety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical PerspectiveC. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. HarringtonCirculation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. HarringtonTime to occurrence of first exploratory major adverse cardiovascular event (MACE). Composit...Show MoreTime to occurrence of first exploratory major adverse cardiovascular event (MACE). Composite of cardiovascular (CV) death, nonfatal myocardial infarction (MI), and stroke. HR indicates hazard ratio.Show Less
- Table 4.Open AccessSafety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical PerspectiveC. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. HarringtonCirculation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
- Table 5.Open AccessSafety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical PerspectiveC. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. HarringtonCirculation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
Pages
Journal
Article Type
Article Type
- ACC/AHA Guideline Revision 2
- ACC/AHA Practice Guideline 1
- ACCF/AHA Focused Update 2
- ACCF/AHA Practice Guideline 58
- ACS: ECG, Angiography, Imaging-Diagnostic, Pathophysiologic, Prognostic Insights 2
- Acute Coronary Syndromes 14
- Acute Coronary Syndromes: Drug Therapies, Bleeding, and Outcomes 1
- Acute Coronary Syndromes: Insights into Risk and Treatment 2
- Acute coronary syndromes 5
- Advances in Antithrombotic Therapies in Acute Coronary Syndromes 1
- Aggregation 8
- Animal models of human disease 8
- Antiplatelets 5
- Antithrombin Therapy for ACS 2
- Arterial thrombosis 8
- Article 7
- Atherosclerosis, Vascular Biology and Development 1
- Basic Science Reports 2
- Brief Rapid Communications 3
- Cardiovascular Perspective 10
- Cardiovascular Pharmacology 4
- Catheter-Based Coronary Interventions: Stent Complications 2
- Catheter-Based Coronary Interventions: Stents: Registry Reports 1
- Catheter-Based Coronary Interventions: Stents: Safety Issues 1
- Catheter-based coronary interventions: stents 7
- Clinical Investigation and Reports 43
- Clinical Investigation and Reports* 1
- Clinical Science 20
- Contemporary STE and NSTE ACS Care 1
- Core 2. Epidemiology and Prevention of CV Disease: Physiology, Pharmacology and Lifestyle 1
- Core 2: Epidemiology and Prevention of CV Disease: Physiology, Pharmacology, and Lifestyle 2
- Core 6. Catheter-based and Surgical Interventions 1
- Core 7. Vascular Disease: Biology and Clinical Science 3
- Coronary Heart Disease 12
- Coronary Interventions 15
- Coronary Stent Thrombosis 2
- Correspondence 3
- Editorial 2
- Epidemiology and Prevention 1
- Featured Research: Thrombin Inhibition, Bleeding, and Outcomes in ACS 4
- Fibrinolysis 8
- Growth factors/cytokines 7
- Health policy and outcome research 5
- In Vitro 1
- Intervention and Surgery 1
- Interventional Cardiology 1
- Journal Article 2
- Lifestyle Factors 1
- New Drugs and Technologies 8
- Original Article 21
- Original Articles 19
- Original Articles Original Article Original Articles 8
- Original Articles Original Article Original Articles Coronary Interventions 7
- Original Research 11
- Original Research Article 10
- Other Vascular biology 7
- Other anticoagulants 5
- Percutaneous Coronary Intervention 6
- Platelet function inhibitors 4
- Platelets 8
- Poster 4
- Poster Session Title: Poster Session III 2
- Prognosis and Pharmacologic Therapy in ACS 1
- Research Support, Non-U.S. Gov't 1
- Research Support, U.S. Gov't, P.H.S. 1
- Review 2
- Risk Factor Interventions: Effects and Impact 2
- Secondary prevention 8
- Session Title: ACS and PCI: 30-Day Outcomes and Posthospitalization Care 1
- Session Title: CTOs, Left Mains, Bifurcations and Multivessel Disease 1
- Session Title: Diabetes Mellitus and CVD: Mechanistic Insights 1
- Session Title: HDL and the Artery Wall 1
- Session Title: Myocardial Protection, Intraoperative Management, and Postoperative Critical Care 1
- Session Title: Poster Session III 4
- Session Title: Unstable Angina, NSTEMI and STEMI: Prognosis and Pharmacologic Therapy-Focus on Patient Risk 1
- Session Title: Unstable Angina, NSTEMI and STEMI: Prognosis and Pharmacological Therapy 1
- Session Title: What's New in the Treatment of Patients with Acute Coronary Syndromes? 1
- Special Report 1
- Special Review 1
- Thrombosis 26
- Type 2 diabetes 14
- Vascular Biology 28
- Vascular Medicine 1
- Volume 126, Issue 21 Supplement; November 20, 2012 / Abstracts From the American Heart Association 2012 Scientific Sessions and Resuscitation Science Symposium 1
Subject
Subject
- AHA Statements and Guidelines 3
- Acute coronary syndromes 24
- Acute myocardial infarction 6
- Aggregation 16
- Animal models of human disease 17
- Anticoagulant mechanisms 9
- Antiplatelets 11
- Arrhythmias, clinical electrophysiology, drugs 1
- Arterial thrombosis 24
- CPR and emergency cardiac care 58
- CV surgery: coronary artery disease 1
- Cardiovascular Disease 11
- Cardiovascular Pharmacology 30
- Catheter-based coronary and valvular interventions: other 7
- Catheter-based coronary interventions: stents 27
- Chronic ischemic heart disease 11
- Coagulation 9
- Coagulation inhibitors 9
- Coronary imaging: angiography/ultrasound/Doppler/CC 2
- Epidemiology 1
- Fibrinolysis 16
- Growth factors/cytokines 14
- Health policy and outcome research 11
- Lipids and Cholesterol 10
- Mechanism of atherosclerosis/growth factors 1
- Mortality/Survival 11
- Other Treatment 1
- Other Vascular biology 14
- Other anticoagulants 18
- Other diabetes 2
- Other diagnostic testing 1
- Other heart failure 1
- Pathophysiology 1
- Platelet function inhibitors 18
- Platelets 26
- Quality and Outcomes 11
- Receptor pharmacology 1
- Restenosis 15
- Risk Factors for Stroke 1
- Secondary prevention 19
- Thrombin 8
- Type 2 diabetes 40
- Volume 126, Issue 21 Supplement; November 20, 2012 / Abstracts From the American Heart Association 2012 Scientific Sessions and Resuscitation Science Symposium 1
Content Type
Resource Type
- Articles 96
- Tables & Figures 136
- HWTABLE 65


